Skip to main content
OpenTrials

Clinical trial condition

TNBC - Triple-Negative Breast Cancer

Explore clinical trials studying TNBC - Triple-Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

53 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

TNBC - Triple-Negative Breast Cancer trial results

Recruiting

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

NCT07017673

Conditions
Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Beverly Hills Los Angeles, California, United States
  • Huntington Cancer Center, an Affiliate of CS Cancer Pasadena, California, United States
  • Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
View Trial Details
Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

NCT05768932

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • University of Miami Health System Coral Gables, Florida, United States
  • Winship Cancer Institute / Emory University Atlanta, Georgia, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 17 locations
View Trial Details
Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

NCT07211178

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Birmingham Hematology Associates Birmingham, Alabama, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Southern Illinois Hospital Services Carbondale, Illinois, United States
View all 14 locations
View Trial Details
Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

NCT06657222

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 16 locations
View Trial Details
Recruiting

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

NCT01042379

Conditions
Angiosarcoma, Breast Cancer, Breast Diseases, +24 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of California - Davis, Comprehensive Cancer Center Davis, California, United States
View all 42 locations
View Trial Details
Recruiting

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

NCT06358573

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations
  • Tumor Zentrum Aarau Aarau, Switzerland
  • St. Claraspital Basel, Switzerland
  • EOC - IOSI Ospedale regionale Bellinzona e valli - San Giovanni Bellinzona, Switzerland
  • Kantonsspital Graubünden Chur, Switzerland
View Trial Details

Related conditions